NEWS

Pharmaceutical Industry news helps our clients to give competitive edge to their customers and also latest pharmaceutical industry news assists them in gaining updated knowledge. We bring you Global Pharmaceutical news about acquisitions, project undertakings, business and marketing, subjects, and industry related subjects, written in a professional, unbiased and thought-provoking format. Our international pharmaceutical News will help you enhance your business knowledge and productivity.

Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as soon as mid-September, after an initial delay. The debt-ridden company is counting on the drug - fremanezumab - along with Huntington’s treatment Austedo, to help it return to growth. Teva and Eli Lilly are in a race…

Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced Allergan plc (NYSE: AGN) has exercised its option to acquire drug candidate AGN-241751, an oral small-molecule N-methyl-D-aspartate (NMDA) receptor modulator. Aptinyx discovered AGN-241751 utilizing its proprietary chemistry platform and the compound was selected for further…

The U.S Food and Drug Administration said on Monday it had approved Dova Pharmaceuticals Inc’s drug to treat low blood platelet count in chronic liver disease (CLD) patients, who are scheduled to undergo a medical procedure. The drug to treat thrombocytopenia belongs to a class of treatments called thrombopoietin receptor…

Eurofins Scientific, a global leader in biopharmaceutical products testing services, announces that it has signed an outsourcing agreement with Astellas to outsource one of its internal testing laboratories Astellas Analytical Science Laboratories, Inc. (“ASL”). ASL was established in 1996 as the core pharmaceutical product testing provider for Astellas Pharma Inc.,…

Roche’s new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed on Monday, setting it up to take a dominant market position. Hemlibra cut by 96 percent the incidence of treated bleeds in hemophilia A patients who did not get…

Histoindex Pte. Ltd., with the world's first stain-free Genesis®200 multiphoton digital pathology system, is collaborating with CymaBay Therapeutics, Inc. to evaluate the efficacy of seladelpar in a randomized, double-blind, placebo-controlled, multi-center Phase 2b study of 175 subjects with biopsy-confirmed Nonalcoholic Steatohepatitis (NASH). Genesis®200's novel imaging technology encompasses Two-Photon Excitation (TPE)…

Catalent Pharma Solutions, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, completed the second phase of a $5.5 million expansion program at its facility in Kansas City, Missouri. The expansion will increase the controlled-substance and controlled-temperature storage capabilities for its clinical…

Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults. The drug, Aimovig, which is given monthly by self-injection, will have a list price of $6,900 a year, or $575 a month, the company…

Dipharma Francis S.r.l., a leading European manufacturer of Active Pharmaceutical Ingredients, is pleased to communicate that it has completed its previously announced acquisition of Kalexsyn, Inc. (Kalexsyn), a world-class Contract Research Organization (CRO) providing chemistry services to the biotechnology and pharmaceutical industry. Pursuant to an agreement dated March 19, 2018,…

Novartis AG today announced that it has completed the acquisition of AveXis, Inc through the consummation of a merger of its indirect wholly-owned subsidiary, Novartis AM Merger Corporation ("Merger Sub"), with and into AveXis without a vote of the AveXis stockholders in accordance with Section 251(h) of the Delaware General…

loadmore..